These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38014679)

  • 1. Nonhypertensive White Matter Hyperintensities in Stroke: Risk Factors, Neuroimaging Characteristics, and Prognosis.
    Lim JS; Lee KJ; Kim BJ; Ryu WS; Chung J; Gwak DS; Lee JS; Kim SE; Ko E; Lee J; Han MK; Smith EE; Kim DE; Bae HJ
    J Am Heart Assoc; 2023 Dec; 12(23):e030515. PubMed ID: 38014679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease.
    Pasi M; Boulouis G; Fotiadis P; Auriel E; Charidimou A; Haley K; Ayres A; Schwab KM; Goldstein JN; Rosand J; Viswanathan A; Pantoni L; Greenberg SM; Gurol ME
    Neurology; 2017 Jun; 88(23):2162-2168. PubMed ID: 28476760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.
    Molad J; Kliper E; Korczyn AD; Ben Assayag E; Ben Bashat D; Shenhar-Tsarfaty S; Aizenstein O; Shopin L; Bornstein NM; Auriel E
    J Alzheimers Dis; 2017; 56(4):1293-1299. PubMed ID: 28157096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of white matter hyperintensities in South Asian patients with transient ischemic attack and minor stroke.
    Hiremath N; Kate M; Mohimen A; Kesavadas C; Sylaja PN
    Neuroradiology; 2020 Oct; 62(10):1279-1284. PubMed ID: 32385557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral microbleeds are associated with deep white matter hyperintensities, but only in hypertensive patients.
    Gao Z; Wang W; Wang Z; Zhao X; Shang Y; Guo Y; Gong M; Yang L; Shi X; Xu X; An N; Wu W
    PLoS One; 2014; 9(3):e91637. PubMed ID: 24626222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodic Limb Movements and White Matter Hyperintensities in First-Ever Minor Stroke or High-Risk Transient Ischemic Attack.
    Boulos MI; Murray BJ; Muir RT; Gao F; Szilagyi GM; Huroy M; Kiss A; Walters AS; Black SE; Lim AS; Swartz RH
    Sleep; 2017 Mar; 40(3):. PubMed ID: 28329254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White Matter Hyperintensity-Associated Blood-Brain Barrier Disruption and Vascular Risk Factors.
    Gupta N; Simpkins AN; Hitomi E; Dias C; Leigh R;
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):466-471. PubMed ID: 29100854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-Specific Associations of Renal Impairment With Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Transient Ischemic Attack and Stroke.
    Liu B; Lau KK; Li L; Lovelock C; Liu M; Kuker W; Rothwell PM
    Stroke; 2018 Apr; 49(4):899-904. PubMed ID: 29523652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI progression of cerebral small vessel disease and cognitive decline in patients with hypertension.
    Uiterwijk R; Staals J; Huijts M; de Leeuw PW; Kroon AA; van Oostenbrugge RJ
    J Hypertens; 2017 Jun; 35(6):1263-1270. PubMed ID: 28169884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of deep white matter hyperintensity with left ventricular hypertrophy in acute ischemic stroke.
    Nagaraja N; Farooqui A; Albayram MS
    J Neuroimaging; 2022 Mar; 32(2):268-272. PubMed ID: 34861077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities.
    Xiong Y; Wong A; Cavalieri M; Schmidt R; Chu WW; Liu X; Wong KS; Mok V
    Neurotherapeutics; 2014 Jul; 11(3):606-11. PubMed ID: 24692001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term progression of white matter hyperintensities in ischemic stroke.
    Holmegaard L; Jensen C; Redfors P; Blomstrand C; Jern C; Jood K
    Acta Neurol Scand; 2018 Dec; 138(6):548-556. PubMed ID: 30152523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White Matter Hyperintensity Volume and Poststroke Cognition: An Individual Patient Data Pooled Analysis of 9 Ischemic Stroke Cohort Studies.
    de Kort FAS; Coenen M; Weaver NA; Kuijf HJ; Aben HP; Bae HJ; Bordet R; Cammà G; Chen CPLH; Dewenter A; Duering M; Fang R; van der Giessen RS; Hamilton OKL; Hilal S; Huenges Wajer IMC; Kan CN; Kim J; Kim BJ; Köhler S; de Kort PLM; Koudstaal PJ; Lim JS; Lopes R; Mok VCT; Staals J; Venketasubramanian N; Verhagen CM; Verhey FRJ; Wardlaw JM; Xu X; Yu KH; Biesbroek JM; Biessels GJ
    Stroke; 2023 Dec; 54(12):3021-3029. PubMed ID: 37901947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension, cerebral Amyloid, aGe Associated Known neuroimaging markers of cerebral small vessel disease Undertaken with stroke REgistry (HAGAKURE) prospective cohort study: Baseline characteristics and association of cerebral small vessel disease with prognosis in an ischemic stroke cohort.
    Ikeda S; Yakushiji Y; Tanaka J; Nishihara M; Ogata A; Eriguchi M; Ono S; Kosugi M; Suzuyama K; Mizoguchi M; Shichijo C; Ide T; Nagaishi Y; Mori H; Ono N; Yoshikawa M; Ide K; Minagawa H; Iida K; Kawamoto K; Katsuki Y; Irie H; Abe T; Hara H
    Front Aging Neurosci; 2023; 15():1117851. PubMed ID: 36936499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A typology of cerebral small vessel disease based on imaging markers.
    Sperber C; Hakim A; Gallucci L; Seiffge D; Rezny-Kasprzak B; Jäger E; Meinel T; Wiest R; Fischer U; Arnold M; Umarova R
    J Neurol; 2023 Oct; 270(10):4985-4994. PubMed ID: 37368130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal white matter hyperintensity changes and cognitive decline in patients with minor stroke.
    Jiang J; Yao K; Huang X; Zhang Y; Shen F; Weng S
    Aging Clin Exp Res; 2022 May; 34(5):1047-1054. PubMed ID: 35084664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging investigation of the intracranial vasculature is warranted in older adults with lacunes of presumed vascular origin.
    Del Brutto OH; Mera RM
    Neuroradiol J; 2022 Oct; 35(5):607-611. PubMed ID: 35369799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.
    Gouw AA; van der Flier WM; Fazekas F; van Straaten EC; Pantoni L; Poggesi A; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Scheltens P; Barkhof F;
    Stroke; 2008 May; 39(5):1414-20. PubMed ID: 18323505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease.
    Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y
    Front Immunol; 2021; 12():803504. PubMed ID: 34956241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline white matter hyperintensities affect the course of cognitive function after small vessel disease-related stroke: a prospective observational study.
    Fruhwirth V; Enzinger C; Fandler-Höfler S; Kneihsl M; Eppinger S; Ropele S; Schmidt R; Gattringer T; Pinter D
    Eur J Neurol; 2021 Feb; 28(2):401-410. PubMed ID: 33065757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.